Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging

Kenji Fukushima, Mehrbod S. Javadi, Takahiro Higuchi, Riikka Lautamäki, Jennifer Merrill, Stephan G. Nekolla, Frank M. Bengel

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

Current noninvasive tests for coronary artery disease detect atherosclerosis or regional ischemia. Global myocardial flow reserve is not routinely identified, although it may be an additional marker of disease development and progression. Methods: For the clinical work-up of suspected or known stable coronary artery disease, 275 individuals had undergone rest-dipyridamole 82Rb myocardial perfusion imaging using PET. In addition to clinical measures of regional perfusion and function, an experimentally validated approach to quantify global myocardial flow reserve was used. Follow-up was obtained for 362 ± 277 d. Results: Myocardial blood flow and flow reserve showed significant correlation to systemic and cardiac hemodynamics and a weak association with risk factors such as age and history of hyperlipidemia. Flow reserve was expectedly lower in subjects with regional ischemia (1.70 ± 0.65 vs. 2.31 ± 0.97 in those without; P < 0.0001), but a wide range was observed in those without regional perfusion abnormalities. We used a composite endpoint of hard and soft events to determine that flow reserve below the median was predictive of adverse outcome in the overall population (P = 0.001) and in subjects with normal regional perfusion (n = 178; P = 0.036), whereas stress flow was predictive only in the overall population (P = 0.001). Ageadjusted multivariate analysis confirmed regional perfusion defects (relative hazard, 2.51; 95% confidence interval, 1.24-5.10; P = 0.009) and low global flow reserve (relative hazard, 2.93; 95% confidence interval, 1.30-6.65; P = 0.011) as independent predictors of cardiac events. Conclusion: In clinical cardiac 82Rb PET, globally impaired flow reserve is a relevant marker for predicting short-term cardiovascular events. It may be used for integration with currently established functional and morphologic test results and for guidance of preventive measures, especially in the absence of regional flow-limiting disease.

Original languageEnglish
Pages (from-to)726-732
Number of pages7
JournalJournal of Nuclear Medicine
Volume52
Issue number5
DOIs
Publication statusPublished - May 1 2011
Externally publishedYes

Fingerprint

Perfusion Imaging
Perfusion
Coronary Artery Disease
Ischemia
Confidence Intervals
Myocardial Perfusion Imaging
Dipyridamole
Hyperlipidemias
Population
Disease Progression
Atherosclerosis
Multivariate Analysis
Hemodynamics

Keywords

  • Coronary artery disease
  • Microvascular dysfunction
  • Myocardial flow reserve
  • Myocardial perfusion
  • PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. / Fukushima, Kenji; Javadi, Mehrbod S.; Higuchi, Takahiro; Lautamäki, Riikka; Merrill, Jennifer; Nekolla, Stephan G.; Bengel, Frank M.

In: Journal of Nuclear Medicine, Vol. 52, No. 5, 01.05.2011, p. 726-732.

Research output: Contribution to journalArticle

Fukushima, Kenji ; Javadi, Mehrbod S. ; Higuchi, Takahiro ; Lautamäki, Riikka ; Merrill, Jennifer ; Nekolla, Stephan G. ; Bengel, Frank M. / Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. In: Journal of Nuclear Medicine. 2011 ; Vol. 52, No. 5. pp. 726-732.
@article{6cf82850a4e8461791942558e63e2644,
title = "Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging",
abstract = "Current noninvasive tests for coronary artery disease detect atherosclerosis or regional ischemia. Global myocardial flow reserve is not routinely identified, although it may be an additional marker of disease development and progression. Methods: For the clinical work-up of suspected or known stable coronary artery disease, 275 individuals had undergone rest-dipyridamole 82Rb myocardial perfusion imaging using PET. In addition to clinical measures of regional perfusion and function, an experimentally validated approach to quantify global myocardial flow reserve was used. Follow-up was obtained for 362 ± 277 d. Results: Myocardial blood flow and flow reserve showed significant correlation to systemic and cardiac hemodynamics and a weak association with risk factors such as age and history of hyperlipidemia. Flow reserve was expectedly lower in subjects with regional ischemia (1.70 ± 0.65 vs. 2.31 ± 0.97 in those without; P < 0.0001), but a wide range was observed in those without regional perfusion abnormalities. We used a composite endpoint of hard and soft events to determine that flow reserve below the median was predictive of adverse outcome in the overall population (P = 0.001) and in subjects with normal regional perfusion (n = 178; P = 0.036), whereas stress flow was predictive only in the overall population (P = 0.001). Ageadjusted multivariate analysis confirmed regional perfusion defects (relative hazard, 2.51; 95{\%} confidence interval, 1.24-5.10; P = 0.009) and low global flow reserve (relative hazard, 2.93; 95{\%} confidence interval, 1.30-6.65; P = 0.011) as independent predictors of cardiac events. Conclusion: In clinical cardiac 82Rb PET, globally impaired flow reserve is a relevant marker for predicting short-term cardiovascular events. It may be used for integration with currently established functional and morphologic test results and for guidance of preventive measures, especially in the absence of regional flow-limiting disease.",
keywords = "Coronary artery disease, Microvascular dysfunction, Myocardial flow reserve, Myocardial perfusion, PET",
author = "Kenji Fukushima and Javadi, {Mehrbod S.} and Takahiro Higuchi and Riikka Lautam{\"a}ki and Jennifer Merrill and Nekolla, {Stephan G.} and Bengel, {Frank M.}",
year = "2011",
month = "5",
day = "1",
doi = "10.2967/jnumed.110.081828",
language = "English",
volume = "52",
pages = "726--732",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "5",

}

TY - JOUR

T1 - Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging

AU - Fukushima, Kenji

AU - Javadi, Mehrbod S.

AU - Higuchi, Takahiro

AU - Lautamäki, Riikka

AU - Merrill, Jennifer

AU - Nekolla, Stephan G.

AU - Bengel, Frank M.

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Current noninvasive tests for coronary artery disease detect atherosclerosis or regional ischemia. Global myocardial flow reserve is not routinely identified, although it may be an additional marker of disease development and progression. Methods: For the clinical work-up of suspected or known stable coronary artery disease, 275 individuals had undergone rest-dipyridamole 82Rb myocardial perfusion imaging using PET. In addition to clinical measures of regional perfusion and function, an experimentally validated approach to quantify global myocardial flow reserve was used. Follow-up was obtained for 362 ± 277 d. Results: Myocardial blood flow and flow reserve showed significant correlation to systemic and cardiac hemodynamics and a weak association with risk factors such as age and history of hyperlipidemia. Flow reserve was expectedly lower in subjects with regional ischemia (1.70 ± 0.65 vs. 2.31 ± 0.97 in those without; P < 0.0001), but a wide range was observed in those without regional perfusion abnormalities. We used a composite endpoint of hard and soft events to determine that flow reserve below the median was predictive of adverse outcome in the overall population (P = 0.001) and in subjects with normal regional perfusion (n = 178; P = 0.036), whereas stress flow was predictive only in the overall population (P = 0.001). Ageadjusted multivariate analysis confirmed regional perfusion defects (relative hazard, 2.51; 95% confidence interval, 1.24-5.10; P = 0.009) and low global flow reserve (relative hazard, 2.93; 95% confidence interval, 1.30-6.65; P = 0.011) as independent predictors of cardiac events. Conclusion: In clinical cardiac 82Rb PET, globally impaired flow reserve is a relevant marker for predicting short-term cardiovascular events. It may be used for integration with currently established functional and morphologic test results and for guidance of preventive measures, especially in the absence of regional flow-limiting disease.

AB - Current noninvasive tests for coronary artery disease detect atherosclerosis or regional ischemia. Global myocardial flow reserve is not routinely identified, although it may be an additional marker of disease development and progression. Methods: For the clinical work-up of suspected or known stable coronary artery disease, 275 individuals had undergone rest-dipyridamole 82Rb myocardial perfusion imaging using PET. In addition to clinical measures of regional perfusion and function, an experimentally validated approach to quantify global myocardial flow reserve was used. Follow-up was obtained for 362 ± 277 d. Results: Myocardial blood flow and flow reserve showed significant correlation to systemic and cardiac hemodynamics and a weak association with risk factors such as age and history of hyperlipidemia. Flow reserve was expectedly lower in subjects with regional ischemia (1.70 ± 0.65 vs. 2.31 ± 0.97 in those without; P < 0.0001), but a wide range was observed in those without regional perfusion abnormalities. We used a composite endpoint of hard and soft events to determine that flow reserve below the median was predictive of adverse outcome in the overall population (P = 0.001) and in subjects with normal regional perfusion (n = 178; P = 0.036), whereas stress flow was predictive only in the overall population (P = 0.001). Ageadjusted multivariate analysis confirmed regional perfusion defects (relative hazard, 2.51; 95% confidence interval, 1.24-5.10; P = 0.009) and low global flow reserve (relative hazard, 2.93; 95% confidence interval, 1.30-6.65; P = 0.011) as independent predictors of cardiac events. Conclusion: In clinical cardiac 82Rb PET, globally impaired flow reserve is a relevant marker for predicting short-term cardiovascular events. It may be used for integration with currently established functional and morphologic test results and for guidance of preventive measures, especially in the absence of regional flow-limiting disease.

KW - Coronary artery disease

KW - Microvascular dysfunction

KW - Myocardial flow reserve

KW - Myocardial perfusion

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=79955777624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955777624&partnerID=8YFLogxK

U2 - 10.2967/jnumed.110.081828

DO - 10.2967/jnumed.110.081828

M3 - Article

C2 - 21498538

AN - SCOPUS:79955777624

VL - 52

SP - 726

EP - 732

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 5

ER -